Labatec Pharma SA
Labatec Pharma SA is a Generics company based in Meyrin (Geneva) recorded by Swissmedic as the authorisation holder for 105 human medicines. That places it 11 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Generics |
|---|---|
| City | Meyrin |
| Canton | Geneva |
| Authorisation holder | Yes |
| Medicines | 105 |
| Founded | 1996 |
| Employees | 11-50 |
| Parent group | Not available |
| Activity | Not available |
| Website | labatec.ch |
Medicines authorised in Switzerland
Labatec Pharma SA is recorded by Swissmedic as the authorisation holder for 105 human medicines. The table shows 48 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
48 of 105 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Aciclovir Labatec | 60325 | A | J05AB01 | 2009-12-15 |
| Actonel 30 mg | 55214 | B | M05BA07 | 2000-12-20 |
| Actonel 35 mg | 69144 | B | M05BA07 | 2024-02-14 |
| Alendronate Labatec 70 mg | 70488 | B | - | 2025-09-02 |
| Amiodarone Labatec | 59528 | B | C01BD01 | 2009-11-20 |
| Anidulafungin Labatec 100 mg | 67756 | A | - | 2020-12-21 |
| Atosiban Labatec 6.75 mg / 0.9 ml | 69185 | B | G02CX01 | 2024-03-04 |
| Atracurium Labatec 10 mg/ml | 60126 | B | M03AC04 | 2010-01-07 |
| Baclocalm 10 mg | 66571 | B | M03BX01 | 2018-12-07 |
| BCG-medac | 69954 | A | L03AX03 | 2026-03-05 |
| Bijuva 1 mg / 100 mg | 68971 | B | G03FA04 | 2024-04-04 |
| Bimatoprost Labatec 0.3 mg/ml | 68391 | B | - | 2022-04-22 |
| Brimonidine Labatec 2 mg/ml | 68527 | B | - | 2023-01-18 |
| Cabazitaxel Labatec 45 mg/4.5 ml | 69233 | A | L01CD04 | 2023-04-20 |
| Carboplatin Labatec 150 mg/15 ml | 62902 | A | L01XA02 | 2012-11-29 |
| Caspofungin Labatec 50 mg | 68433 | A | J02AX04 | 2022-06-16 |
| Cefazolin Labatec 1 g i.v./i.m. | 60009 | A | J01DB04 | 2010-03-24 |
| Ceftriaxon Labatec 250 mg i.m. | 59876 | A | J01DD04 | 2010-02-25 |
| Cefuroxim Labatec i.v. 750 mg | 61475 | A | J01DC02 | 2010-12-06 |
| Clarithro Labatec i.v. 500 mg | 70262 | A | J01FA09 | 2026-07-29 |
| Clarithromycine Labatec 500 mg i.v. | 59480 | A | J01FA09 | 2010-01-29 |
| Co-Amoxicillin Labatec 1 | 68522 | A | J01CR02 | 2022-06-09 |
| Co-Amoxicillin Labatec 2 | 68511 | A | J01CR02 | 2022-06-09 |
| Comboval 10 mg/ml + 3 mg/ml | 69568 | B | N02BE51 | 2024-11-19 |
| Daptomycin Labatec 350 mg | 66651 | A | J01XX09 | 2019-01-23 |
| Desonur 75 mcg | 66179 | B | G03AC09 | 2017-05-02 |
| Dexmedetomidin Labatec 200 μg/2 ml | 69348 | A | N05CM18 | 2024-01-11 |
| Dorzolamide/Timolol Labatec 20.0 mg/ml | 68596 | B | - | 2022-07-07 |
| Duphaston | 28079 | B | G03DB01 | 1963-07-24 |
| Esomeprazol Labatec i.v. 40 mg | 66479 | B | A02BC05 | 2018-01-18 |
| Essenssia 250 mg | 68190 | D | - | 2021-01-29 |
| Femoston 1/10 mg | 53128 | B | G03FB08 | 1996-12-17 |
| Femoston conti 1/5 | 54986 | B | G03FA14 | 1999-09-20 |
| Flagyl | 26314 | B | G01AF01 | 1960-05-14 |
| Flagyl 250 mg | 26313 | B | P01AB01 | 1960-05-14 |
| Fluconazol Labatec 200 mg | 59527 | B | J02AC01 | 2010-01-26 |
| Flumazenil Labatec 0 | 59466 | B | V03AB25 | 2009-12-14 |
| Fluorouracil Labatec 250 mg/5 ml | 65688 | A | L01BC02 | 2016-03-31 |
| Fomina 6.5 mg | 68194 | D | - | 2021-02-01 |
| Fulvestrant Labatec 250 mg/5 ml | 68761 | B | - | 2022-11-22 |
| Ganirelix Labatec 0 | 68549 | A | H01CC01 | 2022-08-04 |
| Hydroxycarbamid Labatec 500 mg | 66131 | A | L01XX05 | 2016-06-30 |
| Imipenem-Cilastatin Labatec | 59764 | A | J01DH51 | 2009-12-18 |
| Intrarosa 6.5 mg | 67323 | B | G03XX01 | 2020-05-19 |
| Irinotecan Labatec 40 mg/2 ml | 59284 | A | L01XX19 | 2009-12-04 |
| Isoniaz-TB 100 mg | 69140 | B | J04AC01 | 2022-12-01 |
| Ketamin Labatec 10 mg/ml | 63231 | B | N01AX03 | 2014-09-19 |
| Letrozol Labatec 2.5 mg | 65164 | B | L02BG04 | 2014-06-24 |
Frequently asked questions
How many medicines does Labatec Pharma SA have authorised in Switzerland?
Labatec Pharma SA is recorded by Swissmedic as the authorisation holder for 105 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Labatec Pharma SA based?
The Swiss location recorded for Labatec Pharma SA is Meyrin, Geneva.
Is Labatec Pharma SA a Swissmedic authorisation holder?
Yes. Labatec Pharma SA appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.